148 related articles for article (PubMed ID: 22188660)
1. Cognitive decline in a patient with anti-glutamic acid decarboxylase autoimmunity; case report.
Takagi M; Yamasaki H; Endo K; Yamada T; Kaneko K; Oka Y; Mori E
BMC Neurol; 2011 Dec; 11():156. PubMed ID: 22188660
[TBL] [Abstract][Full Text] [Related]
2. Cognitive dysfunction associated with anti-glutamic acid decarboxylase autoimmunity: a case-control study.
Takagi M; Ishigaki Y; Uno K; Sawada S; Imai J; Kaneko K; Hasegawa Y; Yamada T; Tokita A; Iseki K; Kanno S; Nishio Y; Katagiri H; Mori E
BMC Neurol; 2013 Jul; 13():76. PubMed ID: 23835051
[TBL] [Abstract][Full Text] [Related]
3. Limbic encephalitis and type 1 diabetes with glutamic acid decarboxylase 65 (GAD65) autoimmunity: improvement with high-dose intravenous immunoglobulin therapy.
Lopez-Sublet M; Bihan H; Reach G; Dupont S; Didelot A; Mourad JJ; Krivitzky A; Dhote R
Diabetes Metab; 2012 Jun; 38(3):273-5. PubMed ID: 22463975
[TBL] [Abstract][Full Text] [Related]
4. Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality?
Blanc F; Ruppert E; Kleitz C; Valenti MP; Cretin B; Humbel RL; Honnorat J; Namer IJ; Hirsch E; Manning L; de Seze J
J Neurol Sci; 2009 Dec; 287(1-2):69-71. PubMed ID: 19786284
[TBL] [Abstract][Full Text] [Related]
5. Lesson of the month 2: Autoimmune sequelae of anti-GAD antibodies - thinking outside the box.
Ward RJ; Varughese GI; Jose B; Abraham RJ
Clin Med (Lond); 2017 Oct; 17(5):473-474. PubMed ID: 28974603
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.
Malter MP; Helmstaedter C; Urbach H; Vincent A; Bien CG
Ann Neurol; 2010 Apr; 67(4):470-8. PubMed ID: 20437582
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
[TBL] [Abstract][Full Text] [Related]
8. The neurological syndromes associated with glutamic acid decarboxylase antibodies.
Baizabal-Carvallo JF
J Autoimmun; 2019 Jul; 101():35-47. PubMed ID: 31000408
[TBL] [Abstract][Full Text] [Related]
9. Acute amnesia and seizures in a young female.
García García ME; Castrillo SM; Morales IG; Di Capua Sacoto D; Dolado AM
Epileptic Disord; 2013 Dec; 15(4):455-60. PubMed ID: 24165308
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus.
Kanter IC; Huttner HB; Staykov D; Biermann T; Struffert T; Kerling F; Hilz MJ; Schellinger PD; Schwab S; Bardutzky J
Epilepsia; 2008 May; 49(5):914-20. PubMed ID: 18177354
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
12. Non-convulsive status epilepticus associated with glutamic acid decarboxylase antibody.
Cikrikçili U; Ulusoy C; Turan S; Yildiz S; Bilgiç B; Hanagasi H; Baykan B; Tüzün E; Gürvit H
Clin EEG Neurosci; 2013 Jul; 44(3):232-6. PubMed ID: 23820312
[TBL] [Abstract][Full Text] [Related]
13. [A case of immune-mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti-glutamic acid decarboxylase antibody].
Kobayakawa Y; Tateishi T; Kawamura N; Doi H; Ohyagi Y; Kira J
Rinsho Shinkeigaku; 2010 Feb; 50(2):92-7. PubMed ID: 20196490
[TBL] [Abstract][Full Text] [Related]
14. Autoimmunity to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).
Klemetti P; Björses P; Tuomi T; Perheentupa J; Partanen J; Rautonen N; Hinkkanen A; Ilonen J; Vaarala O
Clin Exp Immunol; 2000 Mar; 119(3):419-25. PubMed ID: 10691912
[TBL] [Abstract][Full Text] [Related]
15. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
[TBL] [Abstract][Full Text] [Related]
16. Post-carotid endarterectomy changes in cerebral glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography associated with postoperative improvement or impairment in cognitive function.
Yoshida K; Ogasawara K; Saura H; Saito H; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Ogawa A
J Neurosurg; 2015 Dec; 123(6):1546-54. PubMed ID: 26230467
[TBL] [Abstract][Full Text] [Related]
17. Long latency between GAD-antibody detection and development of limbic encephalitis--a case report.
Fauser S; Uttner I; Ariño H; Scherbaum WA; Saiz A; Lewerenz J
BMC Neurol; 2015 Sep; 15():177. PubMed ID: 26420440
[TBL] [Abstract][Full Text] [Related]
18. Are anti-glutamic acid decarboxylase 65-kDa isoform antibodies related to diabetes or brain tumor?
Maimaiti B; Mijiti S; Sun H; Xie Y; Jiang T; Meng Q; Meng H
Eur J Med Res; 2022 Apr; 27(1):53. PubMed ID: 35387690
[TBL] [Abstract][Full Text] [Related]
19. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
Honnorat J; Saiz A; Giometto B; Vincent A; Brieva L; de Andres C; Maestre J; Fabien N; Vighetto A; Casamitjana R; Thivolet C; Tavolato B; Antoine J; Trouillas P; Graus F
Arch Neurol; 2001 Feb; 58(2):225-30. PubMed ID: 11176960
[TBL] [Abstract][Full Text] [Related]
20. Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer.
Kono S; Miyajima H; Sugimoto M; Suzuki Y; Takahashi Y; Hishida A
Intern Med; 2001 Sep; 40(9):968-71. PubMed ID: 11579968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
